Acute exacerbation of interstitial lung disease after procedures

Respir Med. 2019 Apr:150:30-37. doi: 10.1016/j.rmed.2019.02.012. Epub 2019 Feb 12.

Abstract

Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.

Keywords: AE-ILD; Acute exacerbation; Acute exacerbation of interstitial lung disease; Interstitial lung disease; Lung biopsy.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Aged
  • Biopsy / adverse effects*
  • Bronchoalveolar Lavage / adverse effects
  • Bronchoscopy / adverse effects
  • Disease Progression
  • Female
  • Humans
  • Hyperoxia / complications
  • Idiopathic Pulmonary Fibrosis / diagnostic imaging
  • Idiopathic Pulmonary Fibrosis / etiology*
  • Idiopathic Pulmonary Fibrosis / mortality
  • Idiopathic Pulmonary Fibrosis / physiopathology
  • Lung / pathology
  • Lung Diseases, Interstitial / diagnostic imaging
  • Lung Diseases, Interstitial / etiology*
  • Lung Diseases, Interstitial / mortality
  • Lung Diseases, Interstitial / physiopathology
  • Male
  • Middle Aged
  • Prognosis
  • Respiratory Function Tests / methods
  • Risk Factors
  • Tomography, X-Ray Computed / methods